Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory heไalth services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
China's healthcare system is hospital-centric, and most of the inpatient and outpatient care in the country is delivered in public hospitals and basic medical institutions. How✃ever, due to the growing demand ...
168极速一分钟赛车视频记录:View more details
Since China initiated 5G technology R&D and standard formulation in 2013, the landmark national-level policy has been Made in China 2025 🧜issued by the State Council in 2015. 5G technology, along with integrated circuits ...
168极速一分钟赛车视频记录:View more details
The SEA region has had an admirable record in 🐽improving its record against infectious diseases over the neꦫarly three decades from 1990 to 2019. The region’s rapid economic growth relative to the rest of the world has contributed to ...
168极速一分钟赛车视频记录:View more details
In Q3 2020, manufacturing operations in China were completely resumed, and most of the pharmaceutical companies increased their production to meet the growing demand. The demand for COVID-19 relat🧸ed drugs, protective ...
168极速一分钟赛车视频记录:View more details
In the third quarter of 2020, China’s healthcare sector managed to recover from the challenging months of the COVID-19 outbreak in the first half of the year. Nevertheless, COVID-19 continueꦆd to affect the ...
168极速一分钟赛车视频记录:View more details
In the second quarter 2020,🌺 China’s healthcare sector continued be challenged by the COVI🌟D-19 pandemic. As the coronavirus has been affecting the socio-economic reality in the country, in July 2020 China’s State Council released ...
168极速一分钟赛车视频记录:View more details
Healthcare remains in inadequate supply throughout most of the SEA region. The shortage is especially evident in healthcare human resour🌃ces; for instance, apart from Malaysia and China, all the countries in the SEA region have fewer than 1 physician ...
168极速一分钟赛车视频记录:View more details
In early 2020, a worldwide outbreak of coronavirus occurred, affecting the global socio-economic reality. COVID-19 posed a particular challenge to the healthcare industry. Sin𓃲ce the pandemic started in Wuhan, Hubei province, China took a leading role ...
168极速一分钟赛车视频记录:View more details
The growth of China’s healthcare sector continued in the last quarter of 2019, largely stimulated by the on🤡line healthcare segment expansion. The growth was attribu🍸ted to increasing demand for quality healthcare, driven by the country’s ...
168极速一分钟赛车视频记录:View more details
In Q3 2019 China’s healthcare sector continued to expand, stimulated by further structural reforms. 🐟The period saw increased government spending on healthcare, with expenditure on health and family planning growing by 12.1% y🅘/y to RMB 369.3bn. ...
168极速一分钟赛车视频记录:View more details